Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

While every person's journey with PF is unique, columnist Sam Kirton stresses the importance of support groups for patients and caregivers.